MMI Winter 2015 Newsletter

MMI Team Snapshot

  Giuseppe Prisco is CEO at MMI, a medical devices startup he founded in 2011, upon moving to the Pisa area. Previously he was Managing Principal at Intuitive Surgical, leading development projects with yearly budgets in the $5M range for products with $~1B market potential. He  invented and brought to market the daVinci Singles Site product offering, for single port surgery.  He has 15 years experience as individual technical contributor to robotics products such as the 6 axis Adept Robot and the daVinci surgical robot. He holds 27 patents and 63 published patent applications in the fields of controls, robotics, endoscopy and surgery. Giuseppe is a Member of IAG, Italian Angels for Growth, the largest italian business angels group and co-founder of SAMBA, the Sant’Anna Milky Business Angels Network, an investment forum that provides mentoring to local startups.  He is zen Buddhist and has recently become the proud owner of a white puppy.

 

Giuseppe Prisco is CEO at MMI, a medical devices startup he founded in 2011, upon moving to the Pisa area. Previously he was Managing Principal at Intuitive Surgical, leading development projects with yearly budgets in the $5M range for products with $~1B market potential. He  invented and brought to market the daVinci Singles Site product offering, for single port surgery.  He has 15 years experience as individual technical contributor to robotics products such as the 6 axis Adept Robot and the daVinci surgical robot. He holds 27 patents and 63 published patent applications in the fields of controls, robotics, endoscopy and surgery. Giuseppe is a Member of IAG, Italian Angels for Growth, the largest italian business angels group and co-founder of SAMBA, the Sant’Anna Milky Business Angels Network, an investment forum that provides mentoring to local startups.  He is zen Buddhist and has recently become the proud owner of a white puppy.

  Massimiliano Simi is Sr. Mechanical Design Engineer at MMI since 2012, where he does technical design, development and prototyping of new medical devices. During his Ph.D. he worked at the BioRobotics Insitute at the University of Pisa and STORM labs in Nashville, TN. He is an Author of 9 ISI Journal Papers, 18 International Conference Proceedings and 5 Patents and was awarded Best Ph.D. in BioEngineering by the Italian National Bioengineering Group. He is a singer and songwriter, the lead singer and guitarist in a rock band that he has been rocking with his brothers and friends for over ten years!      

 

Massimiliano Simi is Sr. Mechanical Design Engineer at MMI since 2012, where he does technical design, development and prototyping of new medical devices. During his Ph.D. he worked at the BioRobotics Insitute at the University of Pisa and STORM labs in Nashville, TN. He is an Author of 9 ISI Journal Papers, 18 International Conference Proceedings and 5 Patents and was awarded Best Ph.D. in BioEngineering by the Italian National Bioengineering Group. He is a singer and songwriter, the lead singer and guitarist in a rock band that he has been rocking with his brothers and friends for over ten years!

 

 

 

  Hannah Teichmann is Scientist at MMI. She is responsible for the planning and execution of clinical trials, medical clinical literature and comparative care analysis, the coordination of clinical centres and product feedback from clinical centres to MMI. During her Ph.D. in Neuroscience at Stanford she also became active in patient care and advocacy, consulting clients on evidence-based medicine and healthcare decisions in women’s health in the Bay Area. She has published in internationally peer-reviewed journals including Nature Neuroscience. She is trilingual English, German and Italian and speaks conversational French and Spanish, able to work effectively with international clients. She has provided labor support to women at twenty hospital and homebirths, has danced ballet since she was four and is excited to have made her own olive oil this year.

 

Hannah Teichmann is Scientist at MMI. She is responsible for the planning and execution of clinical trials, medical clinical literature and comparative care analysis, the coordination of clinical centres and product feedback from clinical centres to MMI. During her Ph.D. in Neuroscience at Stanford she also became active in patient care and advocacy, consulting clients on evidence-based medicine and healthcare decisions in women’s health in the Bay Area. She has published in internationally peer-reviewed journals including Nature Neuroscience. She is trilingual English, German and Italian and speaks conversational French and Spanish, able to work effectively with international clients. She has provided labor support to women at twenty hospital and homebirths, has danced ballet since she was four and is excited to have made her own olive oil this year.

Matteo Bagheri is a thesis student in aerospatial engineering at Scuola Superiore Sant’Anna carrying out his thesis research at MMI and ready to join the team when he graduates. He spent six months at Stanford and two months at Jet Propulsion Labs in Pasadena during his undergraduate and is an avid basketball player.


Matteo Bagheri is a thesis student in aerospatial engineering at Scuola Superiore Sant’Anna carrying out his thesis research at MMI and ready to join the team when he graduates. He spent six months at Stanford and two months at Jet Propulsion Labs in Pasadena during his undergraduate and is an avid basketball player.

 

Surgeon Survey

You are a great community! 

                     Locations of Surgeons participating in our Surgeon Survey.

                     Locations of Surgeons participating in our Surgeon Survey.

We are letting Surgeon opinion guide our platform design. In the context of a feasibility study carried out for a Horizon2020 grant we won in December 2014, we developed an online survey with few key questions pertinent to guiding our product development. The survey was distributed by us via an email invitation to surgeons we met at the conferences listed above, and by our clinical advisor, Dr. Marco Innocenti inviting select expert microsurgeons and key opinion leaders. These include the presidents of the World Society for Reconstructive Microsurgery, the Italian Society for Microsurgery, the French Society of Microsurgery, the Secretary General of the European Federation of Societies for Microsurgery and the founder of the European School of Microsurgery. Using these two channels we gathered 49 responses. Cumulatively we have responses from a group representing over 4000 annual microsurgeries, while most surgeons participating perform fewer than 100 microsurgeries per year. One goal of our product is to lend dexterity to surgeons who perform small volumes, permitting them to maintain a high, uniform level of quality without practicing microsurgery on a daily basis.  

Surgeon Profession.png
Number of Surgeries.png

We asked surgeons which techniques are the most challenging or where they foresee a robot as an aid. Surgeons envision a wristed robotic instrument to be most useful in the performance of ergonomically difficult anastomoses that are deep within the tissue (deep/far anastomosis), with anastomoses of small vessels of 0.5mm diameter or below and in lymph duct surgery, the new frontier in treating lymphedema, which requires anastomosis of very small diameters. We envision deep/far anastomosis and anastomosis of small diameter vessels or lymph ducts as the primary areas, which will be facilitated by a robot:

·      Being mounted on long shafts, the depth of the anastomosis will no longer be a factor for the surgeon, who will work with the master, designed to be similar to classical instruments surgeons are used to operating with.

·      The surgeons movement will be scaled by the robot, permitting smaller interventions to be performed more easily. Hence a 0.5mm anastomosis, currently beyond the capabilities of most microsurgeons, will be performed with the same ease as a 1mm or above anastomosis.

Furthermore, we found that the prevalent opinion among surgeons(65%) is that microsurgery has not yet found all its applications, but will grow in its implementation. We expect a robotic platform to permit surgeons who would otherwise not have the confidence or expertise to perform microsurgery to integrate microsurgery into their practice after training on the robot. Our prediction is that this would improve outcomes of many interventions in neurosurgery, transplant surgery, cardiovascular surgery and other as yet unexplored specialties. Finally, 75% of surgeons declare a strong interest in emerging technologies such as robotics and imaging, indicating a consensus that the future of surgery will be driven by technologies yet to be developed. Our collaboration with surgeons will result in a product tailored to their needs.